 | Brand Management and Product Leadership |
| |
| Business Operations |
| |
| Clinical Operations |
| |
| Customer Service |
| |
| Human Resources |
| |
| Knowledge Management |
| |
| Market Research, Analytics and Forecasting |
| |
| Marketing Management |
| |
| Medical Affairs |
| |
| New Product Development |
| |
| Patient Focused Services |
| |
 | Product Launch |
| |
| Case Studies in Successful Re-Launch: Zithromax and Wellbutrin  
|
Non-members: Click here to sign-up for a complimentary tour of
"Case Studies in Successful Re-Launch: Zithromax and Wellbutrin"
Study Overview
Successfully re-launching a pharmaceutical product is a difficult feat... (ID 4776)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1365.61
| |
|  |
| Product Relaunch: Setting Strategy for Success
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Relaunch: Setting Strategy for Success"
Study Overview
The need to re-launch a pharmaceutical product can happen for many reasons... (ID 4775)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1126.00
| |
| |
| Sales Force Enthusiasm: Garnering Support for Product Re-Launch
|
Non-members: Click here to sign-up for a complimentary tour of
"Sales Force Enthusiasm: Garnering Support for Product Re-Launch"
Study Overview
Garnering sales force support for a re-launched pharmaceutical product can be a Sisyphean effort... (ID 4774)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1382.00
| |
| |
| Product Re-Launch: Determining the Ideal Marketing Investment
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Re-Launch: Determining the Ideal Marketing Investment"
Study Overview
When product managers endeavor to re-launch a pharmaceutical product, they face numerous obstacles in securing funding for a re-launch and in determining the ideal mix of activities... (ID 4773)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1132.00
| |
| |
| Product Re-Launch Success: Key Findings
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Re-Launch Success: Key Findings"
Study Overview
Re-launching a pharmaceutical product is a marketing challenge that no brand executive wants to face, but many often do... (ID 4772)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $284.00
| |
| |
| Product Character & Position: Choosing Changes for New Growth
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Character & Position: Choosing Changes for New Growth"
Study Overview
Most companies eventually must face the daunting task of re-launching a pharmaceutical product... (ID 4771)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1124.00
| |
| |
| | |
| | |
| | |
| Thought Leader Development for Global Pharmaceutical Launches
|
A pharmaceutical company’s relationship with key thought leaders is vital to the success of a new product because thought leaders communicate opinions and recommendations that are often the deciding factor in influencing a physician to prescribe a new drug... (ID 4569)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...
Price: $768.95
| |
| |
| | |
| Global Marketing Launch Strategy & Structure 
|
In today’s crowded marketplace, pharmaceutical companies must develop a strategy that supports business objectives and forms an effective launch team for their product to achieve attention... (ID 4567)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $812.95
| |
| |
| Quality, Compliance and Regulatory |
| |
| Sales and Marketing |
| |
| Sales Leadership |
| |